ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
BGT007 Cell Treatment of Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2